ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression

Kai Li,1,2,* Ling Yao,1,* Li Chen,1,2 Zhi-Gang Cao,1,2 San-Jian Yu,1,2 Xia-Ying Kuang,1,2 Xin Hu,1 Zhi-Ming Shao1–31Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, 2Department of Oncology, Shanghai Medical College, 3Insti...

Full description

Bibliographic Details
Main Authors: Li K, Yao L, Chen L, Cao ZG, Yu SJ, Kuang XY, Hu X, Shao ZM
Format: Article
Language:English
Published: Dove Medical Press 2014-06-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/id2-predicts-poor-prognosis-in-breast-cancer-especially-in-triple-nega-a17241